Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how Deep Brain Stimulation (DBS) affects people with Parkinson's Disease who experience Freezing of Gait (FOG), a condition where walking suddenly stops. Researchers will conduct MRI scans and various tests before and after DBS to monitor changes in walking and other symptoms over a year. Participants must have Parkinson's Disease with episodes of freezing while walking and plan to undergo DBS surgery.
As a Phase 4 trial, this research focuses on understanding how the already FDA-approved and effective DBS treatment can benefit more patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What is the safety track record for Deep Brain Stimulation (DBS)?
A previous study found Deep Brain Stimulation (DBS) to be safe and well-tolerated. Researchers reported no serious side effects, indicating no major health problems linked to the treatment. The FDA has approved DBS, and it has about 25 years of safety data supporting its use. This extensive testing and application in many patients with Parkinson's Disease demonstrate its reliability. Overall, DBS shows promise in alleviating symptoms like freezing of gait (FOG) while maintaining a strong safety record.12345
Why are researchers enthusiastic about this study treatment?
Researchers are excited about this trial because it focuses on understanding how Deep Brain Stimulation (DBS) affects Parkinson's Disease (PD) patients experiencing freezing of gait (FOG). Unlike typical treatments for PD, which often include medications like Levodopa or physical therapy to manage symptoms, DBS involves implanting a device that sends electrical impulses to specific parts of the brain. This trial aims to identify imaging biomarkers that can predict how well a patient with FOG might respond to DBS. By uncovering these biomarkers, researchers hope to personalize treatment plans, potentially enhancing the effectiveness of DBS for those struggling with this challenging symptom.
What is the effectiveness track record for Deep Brain Stimulation in treating Parkinson's Disease with Freezing of Gait?
Research has shown that Deep Brain Stimulation (DBS), which participants in this trial will undergo, can help with freezing of gait (FOG) in people with Parkinson's disease. One study found that stimulating a specific part of the brain, the subthalamic nucleus, reduced FOG symptoms. However, DBS might not address balance problems in Parkinson's patients. Another study suggested that altering the frequency of the stimulation improved results for FOG. Overall, DBS is considered a useful treatment for managing some symptoms of Parkinson's disease, including FOG.13678
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Assessment
Participants undergo MRI scan, behavioral assessment related to walking, cognitive evaluation, and assessment of other Parkinson's disease symptoms
Post-operative Assessment
Participants repeat assessments including behavioral measures of FOG response and imaging measures of neural response to stimulation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Deep Brain Stimulation (DBS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator